Clinical Trial: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions

U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07421414) titled 'A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions' on Feb. 12.

Brief Summary: The purpose of this clinical trial is to evaluate the pharmacokinetics and the safety after administration of BR1015-A and co-administration of BR1015-3 and BR1015-2 in healthy volunteers under fed conditions

Study Start Date: April 19

Study Type: INTERVENTIONAL

Condition: Essential Hypertension

Intervention: DRUG: BR1015-A

Fimasartan 30 mg/Indapamide 1.5 mg

DRUG: BR1015-3

Fimasartan 30 mg

DRUG: BR1015-2

Indapamide 1.5 mg

Recruitment Statu...